News Releases

Anixa Biosciences Announces Scheduling of Pre-Sub Meeting with FDA for its Cchek™ Cancer Diagnostic Test

October 24, 2018

Moffitt Cancer Center and Anixa Biosciences Announce Completion of Pre-IND Meeting with FDA for CAR-T Therapy

October 22, 2018

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference

October 17, 2018

Anixa Biosciences Files Pre-Submission and Requests Meeting with FDA Regarding Cchek™ Artificial Intelligence based Cancer Detection Technology

October 15, 2018

Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board

October 11, 2018

Anixa Biosciences to Present at Artificial Intelligence Conference

October 5, 2018

ITUS Corporation Changing Company Name to Anixa Biosciences and Stock Ticker Symbol to ANIX

September 28, 2018

Moffitt Cancer Center and ITUS Corporation Announce Scheduling of Pre-IND Meeting with the FDA for their CAR-T Therapy

September 5, 2018

ITUS Corporation to Present at Next Generation Dx Summit

August 17, 2018

Moffitt Cancer Center and ITUS Corporation Request Meeting with FDA Regarding Ovarian Cancer CAR-T Therapy

August 1, 2018

« Previous
1
2
3
4
5
6
7
8
9
10
...15
Next »

Latest News & Events

Mar 2, 2020

Anixa Biosciences Announces Presentation at AI and Big Data in Cancer Conference

Read More...

Feb 12, 2020

Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program

Read More...

Jan 6, 2020

Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.